A latest research report [115+] pages with 360-Degree visibility, titled “CAR-T Cell Therapy Market Share, Size, Trends,…
Category: Primers
Collaborators at the Keio and Osaka Universities Present Key Non-Clinical Data with Stable/Functional-Induced Regulatory T Cells (S/F-iTregs) in Autoimmune Disease Models
RegCell collaborators from Keio University and Osaka University presented key data at ISID 2023 Tokyo Satellite Meeting. Their presentation demonstrated…
Global Microbiome Sequencing Services Market Report 2023: High Cost of Advanced Infrastructure for Sequencing Fuels the Sector
The “Global Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing, Whole…
PetSmart Charities to Name Endowed Chair at UC Davis School of Veterinary Medicine with $6 Million Gift
PetSmart Charities® will name an endowed chair at the University of California, Davis, School of Veterinary Medicine for $6…
National Safety Council Work to Zero Initiative Unveils New Research on Improving Workplace Safety with Robotics
Despite concerted efforts to reduce both serious injury and death on the job, workplace fatality rates…
LivPur Nutrition introduces Cool Lime Hydrate, the newest flavor developed in collaboration with PGA star and LivPur Nutrition investor Justin Thomas
LivPur Nutrition, a consumer-centric nutrition and wellness brand, is proud to launch Cool Lime Hydrate. Working…
Medtronic Extravascular ICD global clinical trial results reinforce device safety and effectiveness
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced longer-term follow-up results of its investigational…
Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies
Boston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company’s key electrophysiology and cardiac…
Rakuten Medical to Start a Global Phase 3 Trial of Alluminox™ Treatment using ASP-1929 for Recurrent Head and Neck Cancer in India
Rakuten Medical, Inc. (Rakuten Medical), a global biotechnology company developing and commercializing precision, cell-targeting therapies based on…
Phio Pharmaceuticals Announces FDA Clearance to Initiate Clinical Trial of PH-762 for Treatment of Skin Carcinomas
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed…